Navigation Links
Atrium Announces the Publication of the COBEST Trial by the Journal of Vascular Surgery
Date:9/29/2011

months compared to BMS.  

In this study, Atrium's Vascular V12 has demonstrated higher long term patency and improved clinical outcomes compared to BMS.  COBEST was an independent investigator initiated study; Atrium Medical had no role in the study design, data collection, data interpretation, or writing of the clinical report.  Atrium provided funding for the study, including the employment of a research assistant.

Dr. Mwipatayi has provided this statement regarding COBEST: "This was the first prospective, randomized, multi center, controlled trial comparing balloon expandable covered stents directly to bare metal stents.  One striking result from the COBEST study was the 5 times lower TVR rate with Atrium's V12 compared to BMS.  This poses a tremendous global economic benefit along with a tremendous quality of life benefit for our patients who are being treated for peripheral vascular disease and more specifically aorto-iliac disease."

About Atrium's Advanta™ V12 covered stent

The Advanta™ Vascular V12 covered stent is a low profile, pre-mounted covered stent made of a radial expandable stainless steel that is completely encapsulated with Atrium's patented one-piece covering technology.  Atrium's patented covering technology creates a thermoconformable microporous PTFE layer that completely encapsulates the stainless steel stent.

Covered stents have been shown to exclude plaque and endothelium, thereby potentially mitigating late luminal loss by halting migration and proliferation of vascular smooth muscle cells and inflammatory cells through open stent struts thus leading to a reduction in restenosis and occlusion rates.  With over 125 clinical publications and over 100,000 patients successfully treated worldwide, this latest publication adds to the rapidly growing body of evidence supporting the safety and efficacy of Atrium's covered stent technology.  The V12 covere
'/>"/>

SOURCE Atrium Medical Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Atrium Medical Corporation Announces First Implant of First-in-Man CINATRA(TM) Voclosporin Coated Coronary Stent
2. Atrium Responds to Bard Suit
3. Atrium Recognized by Business NH Magazine
4. Atrium Recognized by New Hampshire Bio/Medical Council
5. Atrium and Kaneka Launch Xpress-Way™ RX Extraction Catheter in the U.S.
6. Atrium Provides Grant to Establish Education Web Site at AtriumU.com
7. Atrium Honored by the Premier Healthcare Alliance for Operational Excellence
8. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
9. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2015)... 16, 2015 Research and Markets ... the "The Corporate Reputation of Pharma - ... " report to their offering. ... is now in its fourth edition. This report ... 2015). For each annual Corporate Reputation report, the ...
(Date:4/16/2015)... -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ: VNDA ), ... of products for the treatment of central nervous system ... first quarter of 2015 on Wednesday, May 6, 2015, ... will host a conference call at 4:30 PM ET ... will discuss the first quarter 2015 financial results and ...
(Date:4/16/2015)... Calif. , April 16, 2015  Amgen (NASDAQ: ... its first quarter financial results on Tuesday, April 21, ... The announcement will be followed by a conference call ... in the call from Amgen will be Robert ... other members of Amgen,s senior management team. ...
Breaking Medicine Technology:The Corporate Reputation of Pharma - The Global Patient Perspective in 2014 2Vanda Pharmaceuticals to Announce First Quarter 2015 Financial Results on May 6, 2015 2Amgen Announces Webcast Of 2015 First Quarter Financial Results 2
... Olympus, a precision technology leader designing and delivering ... Medical and Surgical Products, Life Science Imaging Systems, ... Audio Products, has announced the call for nominations ... The national program, executed in partnership with the ...
... CID s.r.l., a European company leader in interventional ... their revolutionary drug eluting stent technology during The Drug ... on Wednesday, September 22, 2010.  The lecture, entitled "Status ... delivered by Alexandre Abizaid, MD, PhD. Chief of Intervention ...
Cached Medicine Technology:Olympus Launches 2011 National Innovation Awards Program 2Olympus Launches 2011 National Innovation Awards Program 3Olympus Launches 2011 National Innovation Awards Program 4CID to Update Interventional Cardiologists on Their Drug Eluting Stent Program at TCT 2010 2
(Date:4/17/2015)... Jacksonville, Fla. (PRWEB) April 17, 2015 ... Cancer Center have signed a partnership agreement designed to ... , The institutions have agreed to create a ... Anderson’s treatment protocols and translational research. Baptist MD Anderson ... of 2015, providing a single destination for highly coordinated, ...
(Date:4/17/2015)... April 17, 2015 Scientists from ... multicenter team of U.S. and Venezuelan researchers, have ... in humans among an isolated tribe of Yanomami ... Bacterial diversity in the Yanomami, previously unexposed to ... nearly double that of people living in industrialized ...
(Date:4/17/2015)... TX (PRWEB) April 17, 2015 Connie ... specialist and functional medicine advocate with 30 years of ... will be adding another level of service for her ... her website of 10 recommended wellness books with a ... When asked to explain her interest in providing this ...
(Date:4/17/2015)... (PRWEB) April 17, 2015 Compare-autoinsurance.org has ... the best online auto insurance quotes . ... appropriate financial coverage for their cars. Drivers should always ... to buy. The insurance market is a competitive one, ... offers every hour. , It is now possible ...
(Date:4/17/2015)... 2015 Oxytocin is a ... and thought to help mothers bond to their newborn, ... substantiate this, new studies performed, at NYU Langone Medical ... reported by Medical News Today on April 16, 2015, ... maternal social behavior. The study reveals that, when oxytocin ...
Breaking Medicine News(10 mins):Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 2Health News:Baptist Health and MD Anderson Finalize Agreement to Transform Cancer Care in Region 3Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 2Health News:Mount Sinai Scientists Find Unprecedented Microbial Diversity in Isolated Amazonian Tribe Previously Unexposed to Antibiotics or Processed Foods 3Health News:Connie Casad, M.D. Provides Patients Recommended List of Wellness Books on Website 2Health News:The Best Auto Insurance Quotes Are Available Online! 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 2Health News:Oxytocin Now Found to Help Diet Doc Patients Whose Weight Has Gotten out of Control Due to Emotional Eating Disorders 3
... treatments for heart disease, other conditions , MONDAY, Feb. ... that can change the way cells convert nutrients into ... heart attack, stroke and other conditions. , "Shifts in ... and in response to demanding activities -- like sprinting ...
... , Additional Grants and Donations Total ... and CLEARWATER, Fla. , Feb. 15 Catholic Health ... to support Global Health Ministry,s relief efforts in Haiti . ... use the funds to help rebuild the Hospital St. Francis de Sales ...
... , THE WOODLANDS, Texas , Feb. 15 ... the nation,s largest network including more than 1,300 oncologists and more than ... honored on Feb. 6 , by Texas Governor Rick Perry ... in El Paso, Texas . US Oncology was honored as an ...
... ... forum , ... February 14, 2010 -- Hayes, Inc., the nation’s leading health technology research and consulting ... Technology Research and Consulting, has joined the Medicare Evidence Development and Coverage Advisory Committee ...
... acyclovir is not a replacement for HIV-specific drugs, researchers say ... that people who are infected with both HIV-1, a strain ... could benefit in more than one way by taking a ... medication appears to also slow the progression of HIV. ...
... , , , , BEIJING , ... leading China -based vaccine manufacturer, today announced the completion by,its ... The total consideration for the purchase is approximately RMB120,million ... The,initial payment of RMB56.5 million ( $8.3 million ) ...
Cached Medicine News:Health News:Drugs That Shift Cell's Energy Find New Purpose 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 2Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 3Health News:Catholic Health East and BayCare Health System Pledge $200,000 to Rebuild Hospital in Port-Au-Prince 4Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 2Health News:US Oncology Honored by Texas Governor Perry's Office with Inaugural Governor's Business Hall of Fame Award 3Health News:Hayes Announces Appointment Of Dr Susan Levine To The Medicare Evidence Development and Coverage Advisory Committee (MEDCAC) 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 2Health News:Sinovac Completes Acquisition Aimed at Expanding Production Capacity 3
Femoral selective diagnostic catheter. The material used is nylon (VESTANTM). All selective shapes have thrulumen design. Guidewire campatibility is 0.038". Packaging 5/Box....
... Merit has a complete offering of ... Performa brands, these catheters are designed with ... shaft strength and better push-ability, and large ... in 4, 5, 6 and 7 French ...
The Compass Commander series is engineered to provide the discriminating neurosurgeon with the same capabilities offered within the commander plus+, all in a smaller, lower-cost package....
Used for access and catheterization procedures. Double flexible tipped design permits alternative use of both ends of wire guide depending upon procedural needs. Supplied sterile in peel-open package...
Medicine Products: